Jan A. Staessen

Dec 6, 2024 | ebn.bmj.com | De-Wei An |Jan A. Staessen |KU Leuven

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. CardiologyPublic HealthCommentary on: Su D, Yang H, Chen Z, et al.

Sep 5, 2024 | nature.com | Fang-Fei Wei |Pierpaolo Pellicori |Joao Ferreira |Arantxa González |De-Wei An |Chen Liu | +10 more

AbstractNone of the spironolactone trials in heart failure (HF) assessed the blood pressure (BP) responses to exercise, while conflicting results were reported for exercise capacity. In the HOMAGE trial, 527 patients at increased HF risk were randomized to usual treatment with or without spironolactone (25–50 mg/day). The current substudy included 113 controls and 114 patients assigned spironolactone, who all completed the incremental shuttle walk test at baseline and months 1 and 9.

Dec 11, 2023 | ehp.niehs.nih.gov | Ana Silva |Jan A. Staessen

Research Article : Environmental Health Perspectives Volume 131, Issue 12 CID: 127011 Introduction Over the past 20 y, global life expectancy at birth increased from 67.2 to 73.5 y.1 In line with this remarkable increase in longevity, global exposure to harmful environmental pollutants declined.2 However, from 1990 to 2019, particulate matter (PM) shifted from the fifth rank to the most perilous environmental risk factor and is associated with a 67.7% increase in the number of...